SCHEMBL34462325

SCHEMBL34462325

CCCCNc1ncc2c(n1)[nH]c(=O)n2CCCN1CC2CC1CN2C

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MERTK Q12866 12/20 0.38
▸ TYRO3 Q06418 11/20 0.38
▸ FLT3 P36888 9/20 0.38
▸ GAS6 Q14393 9/20 0.38
▸ TLR7 Q9NYK1 5/20 0.35
▸ AXL P30530 2/20 0.35
▸ ADORA3 P0DMS8 1/20 0.33
▸ PDE4A P27815 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34462314 0.95 MERTK (0.33) MERTKTYRO3FLT3GAS6TLR7
SCHEMBL34462303 0.92 ALDH1A1 (0.35) ADORA3PDE4AADORA2AADORA2BPDE4B
SCHEMBL34462332 0.82 TLR7 (0.36) TLR7ADORA3PDE4AADORA2AADORA2B
SCHEMBL34462171 0.78 TLR7 (0.37) MERTKTYRO3FLT3GAS6TLR7
SCHEMBL34462256 0.75 ADORA2A (0.40) MERTKTYRO3FLT3GAS6TLR7
SCHEMBL34462158 0.74 TLR7 (0.36) MERTKTYRO3FLT3TLR7AXL
SCHEMBL34462349 0.72 MERTK (0.44) MERTKTYRO3FLT3GAS6AXL
SCHEMBL34462260 0.71 DRD3 (0.37) MERTKTYRO3FLT3TLR7AXL
SCHEMBL34462167 0.71 ADORA2A (0.39) MERTKTLR7ADORA2A
SCHEMBL34462336 0.65 ALDH1A1 (0.43) MERTKADORA3ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724442-A1 AGONISM-ANTAGONISM IN ENDOSOMAL TLRS BY MODULATING CHEMICAL FEATURES IN 8-OXOPURINE: PROCESS FOR PREPARATION AND APPLICATION THEREOF Council of Scientific and Industrial Research (IN) 2026-04-15 — — EP disclosed
Send feedback